Startup Quanticel, Fresh off $45M Celgene Deal, Using Fluidigm Tech in Single-Cell Genomic Analyses
November 10, 2011
Startup Quanticel, Fresh off $45M Celgene Deal, Using Fluidigm Tech in Single-Cell Genomic Analyses
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Stanford Group Publishes Fluidigm-Based Method for Gene Expression Profiling of Single Stem Cells
April 12, 2012 / PCR Insider - Fluidigm Cites Single-Cell Genomics, Targeted Resequencing as Driving 25 Percent Q3 Revenue Boost
November 10, 2011 / PCR Insider - Report Sees Continued Growth for Fluidigm as Company Remains 'Interesting' Acquisition Target
May 31, 2012 / PCR Insider - Fluidigm Developing Cellular Sample Prep Platform for Single-Cell Gene Expression, NGS Studies
May 17, 2012 / PCR Insider - As Novartis Prenatal Pact Ends, Fluidigm Offers IP to Others, Continues Single-Cell Genomics Push
May 10, 2012 / PCR Insider